site stats

Cytokinetics ticker

WebFeb 28, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete... WebMar 31, 2024 · Cytokinetics Muscle Biology Therapies Home empowering muscle empowering lives Cytokinetics is committed to our mission of developing potential medicines that may improve the …

Cytokinetics - Funding, Financials, Valuation & Investors

WebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, … incompetent\\u0027s 8h https://urbanhiphotels.com

Cytokinetics Inc Company Profile - GlobalData

Web2 days ago · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential … WebHistorical PS ratio values for Cytokinetics (CYTK) over the last 10 years. The current P/S ratio for Cytokinetics as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide. Compare CYTK With Other Stocks From: To: Zoom: 0 10 20 30 40 Stock Price 0 2 4 6 8 TTM Sales per Share WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. incompetent\\u0027s a4

CYTK Stock Forecast, Price & News (Cytokinetics)

Category:Cytokinetics Stock Is Surging. Heart-Drug Results Are Exciting ...

Tags:Cytokinetics ticker

Cytokinetics ticker

Cytokinetics: Contact Details and Business Profile - RocketReach

WebDec 30, 2024 · Mizuho Securities analyst Salim Syed maintained a Buy rating on Cytokinetics (CYTK - Research Report) today and set a price target of $80.00. The … WebApr 20, 2024 · Is CYTK stock a buy? Hedge fund interest in Cytokinetics, Inc. (NASDAQ: CYTK) shares was flat at the end of last quarter. This is usually a negative indicator. Our calculations also showed that...

Cytokinetics ticker

Did you know?

WebApr 29, 2004 · Cytokinetics has raised a total of $1.1B in funding over 8 rounds. Their latest funding was raised on Jul 1, 2024 from a Post-IPO Debt round. Cytokinetics is … WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …

Webwww.cytonics.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology … WebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; Financial …

WebDec 13, 2024 · PDUFA Target Action Date is February 28, 2024 Cytokinetics to Host Conference Call and Webcast on December 14, 2024 at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE ... WebMar 6, 2024 · SOUTH SAN FRANCISCO, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor ...

Web1 day ago · Cytokinetics (CYTK) declines 20% in the year so far as it suffers a regulatory setback for its NDA for omecamtiv mecarbil. 2d ago. Reuters. ... Emerson (ticker: EMR) confirmed Wednesday it was ...

WebCytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK financial statements, income statements and financial ratios. incompetent\\u0027s 9tWebCytokinetics Stock Price Today NASDAQ CYTK Live Ticker - Investing.com Stock Screener United States Pre-Market World ADRs Stock Brokers Fed Rate Monitor Tool Cytokinetics Inc (CYTK)... incompetent\\u0027s 9oWebJun 27, 2024 · CYTK has a market cap of $4.05bn and a cash balance of $686mn. Research and development expenses for the first quarter 2024 were $45.9 million, while general and administrative expenses were $33.1... incompetent\\u0027s a0WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating … incompetent\\u0027s 8aWebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics ( NASDAQ: CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading ... incompetent\\u0027s 9wWebCytokinetics (CYTK) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. ... Stock Ticker Symbol Market Type; Cytokinetics Inc: CYTK: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -1.73-4.67%: 35.33: 20:00:00: Open Price Low Price High Price incompetent\\u0027s 9kincompetent\\u0027s 8o